XML 58 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
BASIS OF PRESENTATION (Tables)
9 Months Ended
Sep. 29, 2012
Organization, Consolidation, Presentation of Financial Statements and Error Corrections [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
 
Three months ended September 24, 2011
 
Nine months ended September 24, 2011
 
As previously
reported
 
Adjustment
 
As
restated
 
As previously
reported
 
Adjustment
 
As
restated
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Net product revenues
$
28,512

 
$

 
$
28,512

 
$
91,031

 
$

 
$
91,031

Research and development revenues
1,054

 

 
1,054

 
4,901

 

 
4,901

Total revenues
29,566

 

 
29,566

 
95,932

 

 
95,932

Expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of product revenues
19,046

 
707

 
19,753

 
60,107

 
707

 
60,814

Research and development
6,381

 

 
6,381

 
19,905

 

 
19,905

Selling, general and administrative
4,352

 

 
4,352

 
13,495

 

 
13,495

 
29,779

 
707

 
30,486

 
93,507

 
707

 
94,214

(Loss) income from operations
(213
)
 
(707
)
 
(920
)
 
2,425

 
(707
)
 
1,718

Other income and expense:
 
 
 
 
 
 
 
 
 
 
 
Interest income
358

 

 
358

 
987

 

 
987

Other income net
190

 

 
190

 
190

 

 
190

Foreign currency gains
1,013

 

 
1,013

 
375

 

 
375

Gain of sale of investments

 

 

 
369

 

 
369

Impairment of marketable debt securities
(151
)
 

 
(151
)
 
(151
)
 

 
(151
)
Gain on sale of patents

 

 

 
156

 

 
156

 
1,410

 

 
1,410

 
1,926

 

 
1,926

Income (loss) before provision for income taxes, equity losses in unconsolidated affiliates and net income (loss) of noncontrolling interest
1,197

 
(707
)
 
490

 
4,351

 
(707
)
 
3,644

Tax provision
(98
)
 

 
(98
)
 
(293
)
 

 
(293
)
Income (loss) before equity losses in unconsolidated affiliates and net income (loss) of noncontrolling interest
1,099

 
(707
)
 
392

 
4,058

 
(707
)
 
3,351

Equity losses in unconsolidated affiliates
(50
)
 

 
(50
)
 
(204
)
 

 
(204
)
Net income (loss)
1,049

 
(707
)
 
342

 
3,854

 
(707
)
 
3,147

Net (income) loss attributable to the noncontrolling interest
(254
)
 
69

 
(185
)
 
(188
)
 
69

 
(119
)
Net income (loss) attributable to the controlling interest
$
795

 
$
(638
)
 
$
157

 
$
3,666

 
$
(638
)
 
$
3,028

Net income per share:
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.01

 
$
(0.01
)
 
$
0.00

 
$
0.06

 
$
(0.01
)
 
$
0.05

Diluted
$
0.01

 
$
(0.01
)
 
$
0.00

 
$
0.06

 
$
(0.01
)
 
$
0.05

Weighted average number of common shares:
 
 
 
 
 
 
 
 
 
 
 
Basic
64,292

 
 
 
64,292

 
64,519

 
 
 
64,519

Diluted
65,441

 
 
 
65,441

 
65,624

 
 
 
65,624

The effects of this restatement on the consolidated balance sheet as of December 31, 2011 are as follows (in thousands): 
 
December 31, 2011 as previously reported
 
 
 
December 31, 2011 as restated
 
 
Adjustment
 
ASSETS
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and equivalents
$
43,095

 
$

 
$
43,095

Marketable debt securities, at fair value
62,323

 

 
62,323

       Accounts receivable, net of allowance of $513,000 in 2011
16,511

 

 
16,511

Accounts receivable from unconsolidated affiliates
1,341

 

 
1,341

Unbilled receivable
36

 

 
36

Inventory
21,416

 
(947
)
 
20,469

Prepaid taxes
412

 
256

 
668

Prepaid expenses and other current assets
1,294

 

 
1,294

Total current assets
146,428

 
(691
)
 
145,737

Property, plant & equipment, net
32,369

 

 
32,369

Deferred tax assets
4,202

 

 
4,202

Goodwill
1,665

 

 
1,665

Intangible assets
1,954

 

 
1,954

Other assets
7,946

 

 
7,946

Total assets
$
194,564

 
$
(691
)
 
$
193,873

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
Accounts payable
$
12,385

 
$

 
$
12,385

Accrued payroll and expenses
4,183

 

 
4,183

Accrued warranty
1,318

 

 
1,318

Billings in excess of revenue earned
2,467

 

 
2,467

Other accrued liabilities
2,127

 

 
2,127

Total current liabilities
22,480

 

 
22,480

Asset Retirement obligations
1,296

 

 
1,296

Commitments and contingencies
 
 
 
 


Stockholders’ equity:
 
 
 
 
 
Preferred stock
 
 
 
 

Common stock
732

 

 
732

Additional paid-in capital
315,710

 

 
315,710

Treasury stock
(30,995
)
 

 
(30,995
)
Accumulated other comprehensive income
4,146

 

 
4,146

Accumulated deficit
(124,008
)
 
(623
)
 
(124,631
)
Total Kopin Corporation stockholders’ equity
165,585

 
(623
)
 
164,962

Non controlling interest
5,203

 
(68
)
 
5,135

Total stockholder’ equity
170,788

 
(691
)
 
170,097

Total liabilities and stockholders’ equity
$
194,564

 
$
(691
)
 
$
193,873